With the present call the Novo Nordisk Foundation wishes to strengthen Danish clinical research and thus offers active clinical doctors the opportunity to carry out research at a high international level.
Research active doctors employed in full-time clinical positions are eligible to apply.
The fellowship provides half-time substitute replacement salary from the clinical obligations for up to 5 years. The fellowship thus makes it possible for qualified clinical researchers to dedicate half of their time to research. It is however, essential, that the clinical researcher remains 50% associated with clinical work throughout the entire fellowship, to facilitate deep roots of both the research and the researcher in the clinic.
The project and applicant must be anchored at a Danish university, hospital or other non-profit research institution.
The overall goal is to support medical research with clear relevance to patients and human health. The research fields could be within, but not limited to: Patients and disease related research, translational and clinical research, research in disease mechanisms, treatment methods, disease trajectories, epidemiology, diagnostic methods, public health and family medicine, intervention studies, register-based research, proof-of concept studies, pilot projects, clinical trials, and clinical testing etc.
The total fellowship amounts up to DKK 5 million over 5 years. Up to four fellowships will be awarded in 2018.
DKK 500,000 per budget year can be requested to cover salary for a qualified substitute that will undertake part of the applicant’s clinical responsibilities.
DKK 500,000 per budget year can be requested to cover direct operational expenses of the project.
Applications must be completed and submitted using the internet-based application system, which can be accessed via this website from November 22, 2017.
Please read ”information and guidelines for applicants” carefully before initiating the application process. Additional and essential information is found in these guidelines.